Xolair is not a steroid. It belongs to a completely different class of drugs called monoclonal antibodies, which work through a distinct biological mechanism and carry a different side effect profile than corticosteroids like prednisone or inhaled steroids. The confusion is understandable, though, because Xolair treats many of the same conditions that steroids treat, and it’s often prescribed alongside them.
What Xolair Actually Is
Xolair (omalizumab) is a lab-engineered antibody designed to block a specific molecule in your immune system called immunoglobulin E, or IgE. IgE is the substance your body produces during allergic reactions. It latches onto immune cells called mast cells and basophils, triggering them to release the chemicals responsible for swelling, itching, wheezing, and other allergy symptoms.
Xolair works by binding to IgE before it can attach to those immune cells. With less IgE activating those cells, the allergic cascade is dampened at its source. This is a fundamentally different approach from steroids, which suppress inflammation broadly by mimicking hormones your adrenal glands produce. Steroids dial down your entire immune response. Xolair targets one narrow piece of it.
Why the Distinction Matters
Long-term steroid use comes with well-known risks: weight gain, bone thinning, elevated blood sugar, mood changes, and weakened immune defenses. These side effects are a major reason people search for alternatives. Xolair doesn’t carry those steroid-related risks because it doesn’t interact with your hormonal system at all.
In clinical practice, Xolair frequently acts as what doctors call a “steroid-sparing agent,” meaning it reduces or eliminates the need for steroids. In one real-world study of patients with severe allergic asthma who were taking daily oral steroids, roughly half were able to stop or reduce their steroid dose after starting Xolair. Among those who cut back, the average reduction in daily steroid dose was about 74%. A separate study found that 61% of patients taking prednisone for chronic hives no longer needed it after beginning Xolair.
The most commonly reported side effects of Xolair itself are relatively mild: injection-site reactions, headaches, and dizziness. There is a small risk of a severe allergic reaction (anaphylaxis) after the injection, which is why the first several doses are typically given in a medical setting where you’re monitored afterward.
Conditions Xolair Treats
Xolair was first approved in 2003 for moderate to severe allergic asthma in patients six and older whose symptoms aren’t adequately controlled with inhaled corticosteroids alone. It has since been approved for three additional conditions:
- Chronic hives (chronic spontaneous urticaria) in adults and adolescents 12 and older who still have symptoms despite antihistamine treatment
- Chronic sinus inflammation with nasal polyps in adults who haven’t responded well enough to nasal corticosteroid sprays
- Food allergies in adults and children one year and older, to reduce the severity of allergic reactions from accidental exposure to trigger foods
The food allergy approval, granted in early 2024, made Xolair the first medication approved to reduce allergic reactions across multiple food allergens. It doesn’t cure food allergies or allow you to eat trigger foods freely. Instead, it raises the threshold at which your body reacts, offering a safety net against accidental exposure.
How Xolair Is Given
Unlike steroids, which come as pills, inhalers, nasal sprays, or creams, Xolair is given as an injection under the skin. The dose and frequency depend on your body weight and, for asthma patients, your blood IgE levels. Most people receive injections every two to four weeks. After the initial doses are given under medical supervision, some patients can transition to self-injection at home using a prefilled syringe.
One important point from the prescribing information: Xolair is not a rescue medication. It won’t stop an asthma attack or an allergic reaction that’s already happening. It works preventively over time by lowering your baseline IgE levels. If you’re currently taking steroids for any of these conditions, you should not stop them on your own after starting Xolair. Any changes to your steroid regimen need to happen gradually and under medical guidance.